SPONSOR
Peter Siesjö
Total Trials
2
Recruiting
2
Phases
Phase 2
Peter Siesjö is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Glioblastoma, Cerebral Metastases, Meningioma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peter Siesjö
How many clinical trials has Peter Siesjö sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Peter Siesjö, of which 2 are actively recruiting participants. These trials cover conditions including Glioblastoma, Cerebral Metastases, Meningioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peter Siesjö research focus on?
Peter Siesjö clinical trials span Glioblastoma, Cerebral Metastases, Meningioma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peter Siesjö clinical trial?
To participate in a Peter Siesjö trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peter Siesjö trials with current recruitment status updated daily.
Clinical Trials by Peter Siesjö
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology